title: Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene.
abstract: Intracellular signaling induced by the coagulation factors (F) VIIa and Xa is poorly understood. We report here studies on these processes in a human keratinocyte line (HaCaT), which is a constitutive producer of tissue factor (TF) and responds to both FVIIa and FXa with elevation of cytosolic Ca(2+), phosphorylation of extracellular signal-regulated kinase (Erk) 1/2, p38(MAPK), and c-Jun N-terminal kinase, and up-regulation of transcription of the early growth response gene-1 (egr-1). Using egr-1 as end point, we observed with both agonists that phosphatidylinositol-specific phospholipase C and the mitogen-activated protein kinase/Erk kinase/Erk pathway were mediators of the responses. The responses to FVIIa were TF-dependent and up-regulation of egr-1 mRNA did not require presence of the TF cytoplasmic domain. Antibodies to EPR-1 and factor V had no effect on the response to FXa. We have provided evidence that TF is not the sole component of the FVIIa receptor. The requirement for proteolytic activity of both FVIIa and FXa suggests that protease-activated receptors may be involved. We now report evidence suggesting that protease-activated receptor 2 or a close homologue may be a necessary but not sufficient component of this particular signal transduction pathway. The up-regulation of egr-1 describes one way by which the initiation of blood coagulation may influence gene transcription. The ability of these coagulation proteases to induce intracellular signals at concentrations at or below the plasma concentrations of their zymogen precursors suggests that these processes may occur also in vivo.
authors.affiliation: Biotechnology Centre of Oslo, Department of Physiology, Institute of Basic Medical Sciences, University of Oslo, N-0371 Oslo, Norway.
authors.forename: E
authors.initials: E
authors.lastname: Camerer
authors.forename: J A
authors.initials: JA
authors.lastname: Rottingen
authors.forename: E
authors.initials: E
authors.lastname: Gjernes
authors.forename: K
authors.initials: K
authors.lastname: Larsen
authors.forename: A H
authors.initials: AH
authors.lastname: Skartlien
authors.forename: J G
authors.initials: JG
authors.lastname: Iversen
authors.forename: H
authors.initials: H
authors.lastname: Prydz
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D002450:Cell Communication; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000096:biosynthesis / Q000235:genetics*; D004285:Dogs; D051766:Early Growth Response Protein 1; D015942:Factor VIIa / Q000502:physiology*; D015951:Factor Xa / Q000502:physiology*; D006801:Humans; D017874:Immediate-Early Proteins; D015603:Keratinocytes / Q000187:drug effects / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D014157:Transcription Factors / Q000096:biosynthesis / Q000235:genetics*; D015854:Up-Regulation; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
chemical_list: D004268:DNA-Binding Proteins; C497325:EGR1 protein, human; D051766:Early Growth Response Protein 1; D017874:Immediate-Early Proteins; D012333:RNA, Messenger; D014157:Transcription Factors; D010566:Virulence Factors, Bordetella; D015942:Factor VIIa; D015951:Factor Xa; D002118:Calcium